Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with often unfavorable prognosis. Here we summarize the knowledge about diagnosis, epidemiology, pathophysiology and therapy of ACC. Over the recent years multidisciplinary clinics have formed and the first international treatment trials have been conducted. This review focuses on evidence gained from recent basic science and clinical research and provides perspectives from the experience of a large multidisciplinary clinic dedicated to the care of patients with ACC.
Written by:
Else T, Kim A, Sabolch A, Raymond V, Kandathil A, Caoili E, Shruti J, Miller BS, Giordano TJ, Hammer GD Are you the author?
MEND/Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Hospital and Health Systems, University of Michigan
Reference: Endocr Rev. 2013 Jan 1:er20131029. (Epub ahead of print)
doi: 10.1210/er.2013-1029
PubMed Abstract
PMID: 24423978
UroToday.com Adrenal and Kidney Conditions Section
